(19)
(11) EP 3 344 282 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
23.12.2020 Bulletin 2020/52

(45) Mention of the grant of the patent:
23.09.2020 Bulletin 2020/39

(21) Application number: 16766724.5

(22) Date of filing: 30.08.2016
(51) International Patent Classification (IPC): 
A61K 38/47(2006.01)
A61P 1/12(2006.01)
 C12N 9/24(2006.01)
A61P 31/04(2006.01)
(86) International application number:
PCT/US2016/049439
(87) International publication number:
WO 2017/040499 (09.03.2017 Gazette 2017/10)

(54)

GLYCOSIDE HYDROLASES AND THEIR USE IN PREVENTING AND/OR TREATING A PATHOGENIC INFECTION IN AN ANIMAL

GLYCOSIDHYDROLASEN UND DEREN VERWENDUNG ZUR VORBEUGUNG UND/ODER BEHANDLUNG EINER PATHOGENEN INFEKTION BEI EINEM TIER

GLYCOSIDE HYDROLASES ET LEUR UTILISATION DANS LA PRÉVENTION ET/OU LE TRAITEMENT D'UNE INFECTION PATHOGÈNE CHEZ UN ANIMAL

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 02.09.2015 US 201562213564 P

(43) Date of publication of application:
11.07.2018 Bulletin 2018/28

(60) Divisional application:
20161048.2 / 3711773

(73) Proprietor: DuPont Nutrition Biosciences ApS
1411 Copenhagen K (DK)

(72) Inventors:
  • POULSEN, Charlotte Horsmans
    8220 Brabrand (DK)
  • HAANING, Svend
    8464 Galten (DK)

(74) Representative: D Young & Co LLP 
120 Holborn
London EC1N 2DY
London EC1N 2DY (GB)


(56) References cited: : 
WO-A1-94/25061
US-A- 5 433 946
 WO-A2-03/057138
US-A1- 2004 126 370
   
  • DANIELA CHESSA ET AL: "Salmonella enterica serotype Typhimurium Std fimbriae bind terminal [alpha](1,2)fucose residues in the cecal mucosa", MOLECULAR MICROBIOLOGY., vol. 71, no. 4, February 2009 (2009-02), pages 864-875, XP55227127, GB ISSN: 0950-382X, DOI: 10.1111/j.1365-2958.2008.06566.x
  • NAGY B ET AL: "ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC) IN FARM ANIMALS", VETERINARY RESEARCH, ELSEVIER, PARIS, NL, vol. 30, no. 2/03, January 1999 (1999-01), pages 259-284, XP000869753, ISSN: 0928-4249
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).